Quotient Sciences, a global pharmaceutical development, clinical and commercial manufacturing organization, announced today the completion of a $1 million dollar pharmacy and laboratory expansion at their Miami, FL clinical pharmacology facility. The expanded pharmacy capabilities offer customers a quick and cost-effective way to start clinical testing, without the need for...
Medilink East Midlands Member Spreads its Wings during COVID-19
Medilink EM Member Company Afortiori Development has introduced a range of new services to its extensive portfolio during the COVID-19 pandemic. Afortiori Development Ltd is a clinical research company which provides services for the design, planning and management of clinical studies, including post-marketing clinical follow-up and also provides a consulting...
Epidarex Capital Closes New £102 Million UK Venture Fund To Build Successful Life Science Companies
• New UK fund cornerstoned by £50 million investment from the British Business Bank, through its Enterprise Capital Funds (ECF) programme • Epidarex Capital III UK LP will invest in new life science companies from emerging research hubs across the UK, including spinouts from highly regarded universities Epidarex Capital (“Epidarex”),...
Dexamethasone approved to treat COVID-19 patients in the UK
Medicines regulators around the world have pledged to support the rapid approval of medicines to treat COVID-19, where there is adequate evidence of safety and therapeutic benefit. The UK Government has fast-tracked authorisation of the use of well-known corticosteroid, dexamethasone, for the treatment of hospitalised COVID-19 patients requiring oxygen, including...
Plans for a new approach to EU health and pharmaceuticals policy
Following the recent announcements of a new EU4Health Programme, and publication of a Roadmap on timely patient access to affordable medicines, the EU Commission has now launched a far-reaching consultation on its plans for a Pharmaceutical Strategy for Europe. Some of the challenges brought into sharp focus by the COVID-19 crisis will be...
A prioritisation model for COVID 19
By L. Gordon Moore, MD, Senior Medical Director, Clinical Strategy and Value based Care for 3M Health Information Systems How might a health system use existing health information to inform a data-driven priority focussed model in response to COVID 19? Health authorities globally are faced with gaps between supplies and...
Baltex has developed a face mask from 3D fabric to help fight the spread of coronavirus
Award-winning textile firm Baltex has developed a face mask from a pioneering 3D fabric to help tackle the spread of coronavirus. Baltex, a technical textile manufacturer, based in Burr Lane, Ilkeston, Derbyshire, designs, manufactures and supplies a variety of technical textiles for a range of high-performance markets including aerospace, military,...
MHRA update on COVID-19 – 15 June 2020
The below is an update from the MHRA - 15/06/2020 - on the Coronavirus situation For more information on Coronavirus, click here This notice updates you on details of recently published guidance for industry on the coronavirus (COVID-19) pandemic and how we are working closely with our healthcare partners to...
Evolution in the law affecting cannabis-based products
We recently reviewed the law on cannabis-based medicines. It is clear that changes in scientific data and social attitudes mean that producers are faced with rapid evolution and differences in regulatory approach between countries, not only for medicines but for other products too. E-cigarettes containing CBD illegal in France A French case...
Why long-term relationships help your business keep up with rapid technology change
In a world where technology advances on a daily basis, taking a long-term approach to any aspect of business might seem counter-productive. However, building stable, lasting relationships will actually benefit you and help you stay ahead of the market. According to an article in Forbes, the largest threat to global...
